As per the partnership, Alvotech will be responsible for development and supply of the product, whereas Cipla will be responsible for registration and commercialisation of the productfrom Moneycontrol Business News https://ift.tt/310P6Os
Sunday, July 28, 2019
Cipla, Iceland#39;s Alvotech ink pact to sell biosimilar Adalimumab in emerging markets
As per the partnership, Alvotech will be responsible for development and supply of the product, whereas Cipla will be responsible for registration and commercialisation of the productfrom Moneycontrol Business News https://ift.tt/310P6Os
Subscribe to:
Post Comments (Atom)
-
The value had touched a high of 22% of total market capitalisation of listed firms in June 2009, dropping to a low of 5.1% in September 2020...
-
Huawei faces international scrutiny over its ties with the Chinese government and suspicion that Beijing could use Huawei#39;s technology f...
No comments:
Post a Comment